Oral dysbiosis and autoimmunity: from local periodontal responses to an imbalanced systemic immunity. A review

LJ Suárez, H Garzón, S Arboleda… - Frontiers in …, 2020 - frontiersin.org
The current paradigm of onset and progression of periodontitis includes oral dysbiosis
directed by inflammophilic bacteria, leading to altered resolution of inflammation and lack of …

Targeting complement components C3 and C5 for the retina: key concepts and lingering questions

BJ Kim, DC Mastellos, Y Li, JL Dunaief… - Progress in retinal and …, 2021 - Elsevier
Age-related macular degeneration (AMD) remains a major cause of legal blindness, and
treatment for the geographic atrophy form of AMD is a significant unmet need. Dysregulation …

Ischemic heart disease and rheumatoid arthritis—two conditions, the same background

E Rezuș, LA Macovei, AM Burlui, A Cardoneanu… - Life, 2021 - mdpi.com
Rheumatoid arthritis (RA) is one of the most frequent inflammatory rheumatic diseases,
having a considerably increased prevalence of mortality and morbidity due to cardiovascular …

Update of Potential Biomarkers in Risk Prediction and Monitoring of Atherosclerosis in Systemic Lupus Erythematosus to Prevent Cardiovascular Disease

D Blachut, B Przywara-Chowaniec, A Tomasik… - Biomedicines, 2023 - mdpi.com
Systemic lupus erythematosus is a chronic connective tissue disease associated with an
increased risk of premature atherosclerosis. It is estimated that approximately 10% of SLE …

Under crossfire: thromboembolic risk in systemic lupus erythematosus

GA Ramirez, M Efthymiou, DA Isenberg… - Rheumatology, 2019 - academic.oup.com
Cerebral and cardiovascular ischaemic events are frequent complications of SLE and
constitute primary causes of permanent damage. However, the pathogenic determinants of …

Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis

THP Nguyen, I Hokstad, MW Fagerland, TE Mollnes… - PLoS …, 2022 - journals.plos.org
Background The complement system plays an important role in pathophysiology of
cardiovascular disease (CVD), and might be involved in accelerated atherogenesis in …

Immunotherapy for the rheumatoid arthritis-associated coronary artery disease: promise and future

L Wang, Y Zhang, SY Zhang - Chinese Medical Journal, 2019 - mednexus.org
Objective: To review the latest progress on the pathogenic mechanism and management of
rheumatoid arthritis (RA)-associated coronary artery disease (CAD), and propose advice on …

A new monoterpenoid glycoside and a new phenolic glycoside isolated from Dracocephalum moldavica and their anti-complementary activity

J Wang, J Sun, L Jin, M Wang, Y Huang… - Natural Product …, 2023 - Taylor & Francis
A new monoterpenoid glycoside (1 R, 2 R, 4 S)-1, 8-epoxy-p-menthan-2-O-β-D-
glucopyranosyl-(1→ 4)-β-D-glucopyranoside (1) and a new phenolic glycoside, cis-1-(3 …

Complement C3 gene polymorphisms are associated with lipid levels, but not the risk of coronary artery disease: a case-control study

G Cai, L Li, Y Chen, H Huang, L Yu, L Xu - Lipids in Health and Disease, 2019 - Springer
Background Coronary artery disease (CAD) is the leading cause of mortality and morbidity
worldwide. Previous studies have shown that complement component 3 (C3) is associated …

Cell-bound complement activation products (CB-CAPs) have high sensitivity and specificity in pediatric-onset systemic lupus erythematosus and correlate with …

JS Hui-Yuen, Y Gartshteyn, M Ma, T O'Malley… - Lupus, 2018 - journals.sagepub.com
Objective Elevated levels of cell-bound complement activation products (CB-CAPs)(C4d
deposition on B lymphocytes (BC4d) and/or erythrocytes (EC4d)) are sensitive and specific …